arrow
返回

Wilms tumour

delete2021-10-14
delete100
delete
OA
AI
F
Filippo Spreafico *
C
Conrad V. Fernandez
J
Jesper Brok
K
Kayo Nakata
G
Gordan Vujanić
J
James I. Geller
M
Manfred Gessler
M
Mariana Maschietto
S
Sam Behjati
A
Angela Polanco
V
Vivian Paintsil
S
Sandra Luna‐Fineman
K
Kathy Pritchard‐Jones
DOI:10.1038/s41572-021-00308-8delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Wilms tumour (WT) is the most common renal tumour in infants and young children. This Primer reviews the epidemiology, mechanisms, diagnosis and management of WT. In addition, the authors outline potential opportunities to translate novel biological targets to improve clinical outcomes. Wilms tumour (WT) is a childhood embryonal tumour that is paradigmatic of the intersection between disrupted organogenesis and tumorigenesis. Many WT genes play a critical (non-redundant) role in early nephrogenesis. Improving patient outcomes requires advances in understanding and targeting of the multiple genes and cellular control pathways now identified as active in WT development. Decades of clinical and basic research have helped to gradually optimize clinical care. Curative therapy is achievable in 90% of affected children, even those with disseminated disease, yet survival disparities within and between countries exist and deserve commitment to change. Updated epidemiological studies have also provided novel insights into global incidence variations. Introduction of biology-driven approaches to risk stratification and new drug development has been slower in WT than in other childhood tumours. Current prognostic classification for children with WT is grounded in clinical and pathological findings and in dedicated protocols on molecular alterations. Treatment includes conventional cytotoxic chemotherapy and surgery, and radiation therapy in some cases. Advanced imaging to capture tumour composition, optimizing irradiation techniques to reduce target volumes, and evaluation of newer surgical procedures are key areas for future research.
Keyword:
CHILDRENS ONCOLOGY GROUP
STAGE RENAL-DISEASE
INTERNAL TANDEM DUPLICATIONS
2ND MALIGNANT NEOPLASMS
CLEAR-CELL SARCOMA
AT-RISK CHILDREN
SIOP WT 2001
CHILDHOOD-CANCER
PROGNOSTIC-FACTORS
NEPHROGENIC RESTS

期刊

N
Nature Reviews Disease Primers
IF:
60.6
论文数:
650
被引数:
3.8W

机构

U
University of Copenhagen
学者数:
7.6W
论文数: 6.6W
被引数: 86
U
University of Cincinnati
学者数:
1.8W
论文数: 1.4W
被引数: 2.2W
R
Rigshospitalet
学者数:
1.7W
论文数: 1.3W
被引数: 2.1W
U
University System of Ohio
学者数:
15.5W
论文数: 13.0W
被引数: 200
U
University of Cambridge
学者数:
7.7W
论文数: 7.1W
被引数: 13.7W
S
sidra medical & research center
学者数:
1.3K
论文数: 886
被引数: 0
D
Dalhousie University
学者数:
2.0W
论文数: 1.8W
被引数: 2.3W
U
University of Wurzburg
学者数:
2.5W
论文数: 2.0W
被引数: 2.5W
F
fondazione irccs istituto nazionale tumori milan
学者数:
1.1W
论文数: 6.5K
被引数: 4
W
wellcome trust sanger institute
学者数:
6.9K
论文数: 4.3K
被引数: 17
学者 查看更多机构
引用论文

引用论文

err
IF0
err
err0
PREAI
err
err分享
err收藏
UT-MUC-1, a New Mucoepidermoid Carcinoma Cell Line, and Its Radiosensitivity
err1992-05-01
err0
PREAI
errR. Grenman; K. Pekkola-Heino; H. Joensuu; K. Aitasalo; P. Klemi; T. Lakkala
err分享
err收藏
err分享
err收藏
学者 查看更多内容